/
ARTL
$0.80+$0.03 (+3.51%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$2.6M
3M shares
52-week range
$0.71 – $31.65
0% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Change$-218.99
Artelo Biosciences, Inc. Common Stock
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.
www.artelobio.com- Employees
- 7
- IPO / List date
- Oct 13, 2015
- HQ
- SOLANA BEACH, CA
Held by traders on TradeandTell
No one on the platform currently holds ARTL.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in ARTL as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2026-03-10 | 1-for-3reverse |
| 2025-06-13 | 1-for-6reverse |
| 2022-08-10 | 1-for-15reverse |
| 2019-06-21 | 1-for-8reverse |
Recent trades on TradeandTell
No one on the platform has traded ARTL yet.
